Omnipod 5 now works with the Dexcom G7 in the UK: what changes
From early 2025, the tubeless Omnipod 5 hybrid closed loop can pair with the Dexcom G7 sensor in the UK. Here is what that combination offers and who it is for.
If you use an Omnipod 5 pump, or you are waiting for one, it can now take its glucose readings from a third sensor in the UK: the Dexcom G7. Diabetes UK confirmed this on 26 February 2025. It is a compatibility update, not a new pump and not a cure. Omnipod 5 is a tubeless hybrid closed loop, so the pod sits straight on your skin and adjusts your background insulin using the sensor. You still dose for meals, and whether it suits you runs through your NHS diabetes team.
- A hybrid closed loop is a pump and glucose sensor that talk to each other, so the pump adjusts your background insulin (the steady drip that runs day and night) by itself.
- The new part is only the sensor list: Dexcom G7 joins the Libre 2 Plus and Dexcom G6 that Omnipod 5 already worked with.
- Hybrid means it is not hands-off; you still count carbs and give the mealtime dose, and it is not a cure.
- You still treat lows yourself with fast sugar: automation lowers the day-to-day load, it does not remove it.
- Whether you are eligible, and how you would get it, go through your NHS diabetes team, not something you switch to alone.
A new sensor option, not a new pump
On 26 February 2025, Diabetes UK confirmed that Omnipod 5 can pair with the Dexcom G7 in the UK. Until then it worked with the FreeStyle Libre 2 Plus and the Dexcom G6. The pump and the algorithm inside it are the same; the only change is that it can now read glucose from the G7 too.
A continuous glucose monitor, or CGM, is the small sensor worn on your skin that checks glucose every few minutes and sends the number over automatically. Which one suits a given person is not one-size-fits-all: they differ in how long each lasts, how you start it, and the alarms. That is a conversation with your team, not a rush to the newest one.
What a tubeless closed loop actually does
The pod is the insulin pump itself: it sticks to your skin with no tubing, and you control it from a handset or phone app. Every few minutes it reads your sensor and makes small changes to your background insulin, easing it up when you drift high and reducing or pausing it when you head low. Some people call this an artificial pancreas, though it is only partly automatic.
That is the key point. The system handles the slow between-meals drift and the overnight hours, where a lot of the mental load and lost sleep usually sit. But you still count the carbs in a meal and give the dose, and you still act on a low. How much steadier your numbers get varies with the sensor, your meals, and the settings your team sets up with you.
Available now, with eligibility as the gate
This is not a far-off or overseas-only launch: Omnipod 5 is available in the UK now, and hybrid closed loop systems are being rolled out on the NHS. The honest position is that the technology is here, but it comes with eligibility criteria, so whether and when you get it depends on those and your local service, through your specialist diabetes team, rather than on the sensor news itself.
What this looks like differs from person to person
None of this lands the same for everyone. One person finds a closed loop steadies their nights and frees up headspace; another finds the difference smaller, or the alarms harder to live with. That is why it is worked out with your team rather than read off a spec sheet.